INTERNATIONAL MYELOMA SOCIETY
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$11,815,468
Contributions
96%
Investments
4%
Membership Dues
<1%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Other
0%
Expenses in 2024
$9,724,228
Other
67%
Grants
28%
Advertising & Promotion
4%
Salaries & Benefits
1%
Fees to Service Providers
<1%
Offices, Occupancy & IT
<1%
Benefits to Members
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$11,341,839
$11,288,193
0%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$0
-
Membership Dues
$87,011
$76,710
-12%
Investments
$0
$450,565
-
Other
$0
$0
-
Total Revenues
$11,428,850
$11,815,468
+3%
Expenses
2023
2024
Change
Grants
$3,277,910
$2,746,726
-16%
Benefits to Members
$0
$0
-
Salaries & Benefits
$74,702
$109,532
+47%
Fees to Service Providers
$776,500
$29,570
-96%
Advertising & Promotion
$229,286
$345,962
+51%
Offices, Occupancy & IT
$35,700
$23,541
-34%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$5,050,874
$6,468,897
+28%
Total Expenses
$9,444,972
$9,724,228
+3%
Net income
2023
2024
Change
Net income
+$1,983,878
+$2,091,240
+5%
Functional Expenses
Summary
2023
2024
Change
Program
$9,378,099
$9,152,970
-2%
Admin
$66,873
$571,258
+754%
Fundraising
$0
$0
-
Total Expenses
$9,444,972
$9,724,228
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)